From: Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives
Compound | R | R 1 | R 2 | R 3 | R 4 | R 5 | MIC (μg/mL) | |||
---|---|---|---|---|---|---|---|---|---|---|
Ec | Pa | Sa | Kp | |||||||
8a |
| H | H | H | H | H | > 50 | > 50 | 50 | 12.5 |
8b |
| H | H | CF3 | H | H | > 50 | > 50 | 50 | 12.5 |
8c |
| H | H | Br | H | H | > 50 | > 50 | 50 | 12.5 |
8d |
| H | H | Cl | H | H | > 50 | > 50 | > 50 | 12.5 |
8e |
| H | H | CH3 | H | H | > 50 | > 50 | > 50 | 25 |
8f |
| H | H | F | H | H | > 50 | > 50 | > 50 | 50 |
8g |
| CF3 | H | H | H | H | > 50 | > 50 | > 50 | > 50 |
8h |
| F | F | F | F | F | > 50 | > 50 | > 50 | > 50 |
8i |
| H | H | Br | H | H | > 50 | > 50 | > 50 | > 50 |
8j |
| H | H | F | H | H | > 50 | > 50 | > 50 | > 50 |
8k |
| H | H | Br | H | H | > 50 | > 50 | > 50 | > 50 |
8l |
| H | H | CF3 | H | H | > 50 | > 50 | > 50 | > 50 |
8m |
| H | H | Br | H | H | > 50 | > 50 | > 50 | > 50 |
8n |
| H | H | Cl | H | H | > 50 | > 50 | > 50 | > 50 |
8o |
| H | Br | H | H | H | > 50 | > 50 | > 50 | > 50 |
8p |
| H | Cl | H | H | H | > 50 | > 50 | > 50 | > 50 |
8q |
| H | F | H | H | H | 50 | > 50 | > 50 | > 50 |
11 | - | - | - | - | - | - | > 50 | > 50 | > 50 | > 50 |
Gentamycin | - | - | - | - | - | - | 0.78 | 0.78 | 0.39 | 0.78 |
Ampicillin | - | - | - | - | - | - | 50 | 50 | 0.19 | 0.39 |